Literature DB >> 8040837

Production of interleukin-6 and interleukin-8 by human mammary gland epithelial cells.

K H Palkowetz1, C L Royer, R Garofalo, H E Rudloff, F C Schmalstieg, A S Goldman.   

Abstract

The production of transforming growth factor-beta 2 (TGF-beta 2), interleukin-1 beta (IL-1 beta), IL-6, IL-8, and tumor necrosis factor-alpha (TNF-alpha) by spontaneously immortalized human mammary gland epithelial cells of non-malignant origin and the effect of prolactin upon the production of those cytokines were investigated. Cells were cultured on plastic with epithelial growth factor, insulin, and hydrocortisone. Cytokines were quantified by enzyme-immunoassays. The cells produced IL-6 and IL-8, but no detectable TGF-beta 2, IL-1 beta, or TNF-alpha. Although prolactin enhanced the uptake of [3H]thymidine, it did not alter the production of cytokines/interleukins. Because of the marked production of IL-8 by mammary epithelium and a past report of TGF activity in human milk, those agents were quantified in human milk. The mean +/- S.D. concentrations of IL-8 and TGF-beta 2 in human milk obtained in the first 3 days of lactation were 3684 +/- 2910 and 130 +/- 108 pg/ml, respectively. Thus, IL-8 and TGF-beta 2 are normal constituents in human milk, and human mammary gland epithelium may be responsible for producing some of the IL-6 and IL-8 in human milk.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8040837     DOI: 10.1016/0165-0378(93)00867-s

Source DB:  PubMed          Journal:  J Reprod Immunol        ISSN: 0165-0378            Impact factor:   4.054


  13 in total

1.  Breast is best.

Authors:  G Gathwala; A Narang
Journal:  Indian J Pediatr       Date:  1995 Nov-Dec       Impact factor: 1.967

2.  Inducible and constitutive in vitro neutrophil chemokine expression by mammary epithelial and myoepithelial cells.

Authors:  M R Barber; A G Pantschenko; L S Hinckley; T J Yang
Journal:  Clin Diagn Lab Immunol       Date:  1999-11

3.  The Tumor-Promoting Flow of Cells Into, Within and Out of the Tumor Site: Regulation by the Inflammatory Axis of TNFα and Chemokines.

Authors:  Adit Ben-Baruch
Journal:  Cancer Microenviron       Date:  2011-12-22

4.  Chemotactic activities in nonmastitic and mastitic mammary secretions: presence of interleukin-8 in mastitic but not nonmastitic secretions.

Authors:  M R Barber; T J Yang
Journal:  Clin Diagn Lab Immunol       Date:  1998-01

Review 5.  Cytokines in human milk: properties and potential effects upon the mammary gland and the neonate.

Authors:  A S Goldman; S Chheda; R Garofalo; F C Schmalstieg
Journal:  J Mammary Gland Biol Neoplasia       Date:  1996-07       Impact factor: 2.673

6.  The effects of probiotic supplementation on the gene expressions of immune cell surface markers and levels of antibodies and pro-inflammatory cytokines in human milk.

Authors:  Veronique Demers-Mathieu; Gabrielle B Mathijssen; Ciera DaPra; Elena Medo
Journal:  J Perinatol       Date:  2020-11-18       Impact factor: 2.521

7.  Microarray analysis of human milk cells: persistent high expression of osteopontin during the lactation period.

Authors:  T Nagatomo; S Ohga; H Takada; A Nomura; S Hikino; M Imura; K Ohshima; T Hara
Journal:  Clin Exp Immunol       Date:  2004-10       Impact factor: 4.330

8.  Traffic of endogenous, transduced, and endocytosed prolactin in rabbit lacrimal acinar cells.

Authors:  Yanru Wang; Christopher T Chiu; Tamako Nakamura; Ameae M Walker; Barbara Petridou; Melvin D Trousdale; Sarah F Hamm-Alvarez; Austin K Mircheff; Joel E Schechter
Journal:  Exp Eye Res       Date:  2007-08-24       Impact factor: 3.467

9.  Human milk composition differs in healthy mothers and mothers with celiac disease.

Authors:  Marta Olivares; Simone Albrecht; Giada De Palma; María Desamparados Ferrer; Gemma Castillejo; Henk A Schols; Yolanda Sanz
Journal:  Eur J Nutr       Date:  2014-04-04       Impact factor: 5.614

10.  Soluble form of ICAM-1, VCAM-1, E- and L-selectin in human milk.

Authors:  K Xyni; D Rizos; G Giannaki; A Sarandakou; I Phocas; G Creatsas
Journal:  Mediators Inflamm       Date:  2000       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.